CVE-2022-20711 | Multiple vulnerabilities in Cisco Small Business RV160, RV260, RV340, and RV345 Series Routers could allow an attacker to do any of the following: Execute arbitrary code Elevate privileges Execute arbitrary commands Bypass authentication and authorization protections Fetch and run unsigned software Cause denial of service (DoS) For more information about these vulnerabilities, see the Details section of this advisory.
Multiple vulnerabilities in Cisco Small Business RV160, RV260, RV340, and RV345 Series Routers could allow an attacker to do any of the following: Execute arbitrary code Elevate privileges Execute arbitrary commands Bypass authentication and authorization protections Fetch and run unsigned software Cause denial of service (DoS) For more information about these vulnerabilities, see the Details section of this advisory.
```Code``` unterstützt. Zero-Day & Vulnerability Intelligence Hub
Echtzeit-Tracking mit EPSS Exploit-Wahrscheinlichkeiten, Angriffsvektor-Decodern und KI-Patch-Anleitungen.
📊 Historien-Charts — Criticals-Trend · Vendors · EPSS-Verteilung
| Tier | CVEs | Anteil |
|---|---|---|
| ≥90 % | 720 | 0,2 % |
| ≥50 % | 3.223 | 0,9 % |
| ≥10 % | 22.114 | 6,0 % |
| <10 % | 342.003 | 92,9 % |
CVE-2022-20711 | Multiple vulnerabilities in Cisco Small Business RV160, RV260, RV340, and RV345 Series Routers could allow an attacker to do any of the following: Execute arbitrary code Elevate privileges Execute arbitrary commands Bypass authentication and authorization protections Fetch and run unsigned software Cause denial of service (DoS) For more information about these vulnerabilities, see the Details section of this advisory.
Multiple vulnerabilities in Cisco Small Business RV160, RV260, RV340, and RV345 Series Routers could allow an attacker to do any of the following: Execute arbitrary code Elevate privileges Execute arbitrary commands Bypass authentication an
Noch keine Analyse zu CVE-2022-20711
Sei der Erste: Einschätzung, Betroffenheit, Workaround oder PoC — mit Antworten im Thread.